T/HENANPA 010-2023 The evaluation index system for statin drugs in medical institutions
T/HENANPA 010-2023 The evaluation index system for statin drugs in medical institutions
Basic Information
Scope
Main technical content: The "Evaluation Index System for Statins in Medical Institutions" follows the principles of openness, transparency, and fairness. It is based on relevant guidelines and combines the characteristics of clinical drug use. It widely adopts the opinions of drug users, monitors, and managers in medical institutions, and the evaluation standards are highly scientific, specific, and timely. They can be used as a reference by medical institutions at all levels. It is conducive to promoting the selection of drug lists in medical and health institutions and the connection between drug lists of higher and lower-level medical and health institutions, improving the level of pharmaceutical services and rational use of statins, controlling unreasonable drug expenditure, and enhancing the efficiency of health resource allocation. It has great application value.